A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma. - Akkad N; Feng L; Westin JR; Hagemeister FB; Lee HJ; Fayad L; Ahmed S; Nair R; Rodriguez MA; Strati P; Chihara D; Flowers CR; et al. (Blood advances, 2025)